The diastolic aspect of LOXL2 effects is particularly important, given the recognition and increasing prevalence of diastolic dysfunction as part of HF syndrome and the lack of approved therapy for HFpEF with primarily diastolic failure. This evidence concerns the gene LOXL2 and hydrops fetalis.